Not an actual patient
REYATAZ can help you get to undetectable*
and increase your CD4+ T cell count
A key 96-week clinical trial compared a REYATAZ and ritonavir-based treatment
regimen to a lopinavir/ritonavir-based regimen.
The clinical trial
This 96-week clinical trial looked at 878 adults living with HIV-1 who:
- Were new to HIV therapy
- Had a moderate viral load (average of 87,096 HIV copies/mL)
- Had a weakened immune system (average CD4+ cell count of 204 cells/mm3)
Patients were split into two study groups, each of which took different meds
- At 96 weeks, viral load and T cell count were measured in both study groups.
What side effects can REYATAZ cause?
REYATAZ may cause side effects in some people. Some of the side effects caused by REYATAZ can be serious.
- Talk to your prescribing physician about any side effect that may be bothering you. Your prescribing physician can work with you to manage side effects throughout your treatment.
The most common side effects include:
- stomach-area pain
- trouble sleeping
- numbness, tingling, or burning of hands or feet
- muscle pain